Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

Shares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring focused on large genetic liver diseases and cystic fibrosis, alongside ...

Mind Medicine (NASDAQ: MNMD) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session.

Mind Medicine is a company very few people have heard of. Its stock is up almost 50% today. Why? A college student made roughly $110 million trading Bed Bath & Beyond, according to SEC filings.